Hospitals warn CGHS reimbursement cap could cut off lifesaving immunotherapy for cancer patients

Nine immunotherapy drugs are becoming effectively unreachable

A major private hospital group has warned that a reimbursement cap under the Central Government Health Scheme is straining finances for hospitals treating advanced cancer. The cap on life-saving immunotherapy drugs is pushing essential medicines beyond affordability for many CGHS beneficiaries, according to the association, which says nine specific drugs are now out of reach and may limit access to treatment.